Ellipsis Health, a leading healthcare technology company specializing in AI-generated vocal biomarker technology for mental health, has announced its sponsorship of the Asia-Pacific Economic Cooperation (APEC) Summit. This partnership reflects Ellipsis Health’s commitment to advancing mental healthcare and raising awareness for improved access to treatment.
The current state of mental healthcare calls for innovation and increased access. It is estimated that approximately half of the global population will experience some form of mental health disorder by the age of 75. However, there is an average delay of 11 years between symptom onset and treatment, and over 50% of individuals with mental health conditions do not receive the necessary care. Furthermore, there is an anticipated shortage of up to 30,000 psychiatrists in the near future, and many communities lack access to necessary resources. Ellipsis Health aims to address these gaps in the system by leveraging AI and technological advancements to amplify existing medical resources and increase efficiency in mental health screening and care.
By using vocal biomarkers as a means of identifying conditions such as anxiety and depression, Ellipsis Health bridges the gap between physical and mental health. This approach helps destigmatize mental health conditions and promotes a more holistic understanding of overall well-being. As part of its efforts, Ellipsis Health has partnered with Cigna Healthcare and International Health to develop StressWaves, a publicly available tool that utilizes voice and AI to assess stress levels and connect individuals with appropriate resources for support.
Ellipsis Health’s sponsorship of the APEC Summit aligns with the summit’s focus on resilience, innovation, and inclusivity. This collaboration showcases the company’s confidence in innovation and workforce talent, as well as its commitment to fostering economic development. The City and County of , represented by its Chief of Protocol, recognizes and supports Ellipsis Health’s dedication to improving mental healthcare and looks forward to welcoming APEC attendees to the city.
Founded in 2017, Ellipsis Health is backed by prominent investors and collaborates with providers, payers, and digital health companies to enhance the quality and efficiency of mental health care. The company’s vocal biomarker technology enables early detection, assessment, and monitoring of clinical anxiety and depression, ultimately driving improved patient outcomes, shortened diagnosis time, and reduced costs.
APEC represents a key platform for advancing economic policies and promoting inclusive and sustainable growth. As the host of the 2023 APEC Leaders’ Meeting, will contribute to the region’s economic development and global trade. With 21 member economies accounting for a significant portion of the global population and trade, APEC’s focus on sustainability, inclusivity, innovation, and resilience will shape discussions and collaborations during the summit.
In conclusion, Ellipsis Health’s sponsorship of the APEC Summit highlights its commitment to improving mental healthcare and raising awareness for increased access to treatment. By leveraging AI-generated vocal biomarkers, the company aims to bridge the gap between physical and mental health and de-stigmatize mental health conditions. This collaboration aligns with APEC’s objectives and signifies a collective effort towards a more inclusive and innovative future.